Hanwha Life (088350) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Hanwha Life stock KRW 7,800, price KRW 3,900, upside +100.0%, quality 47 out of 100. Rating: strongly undervalued. Calculated from audited financials with 6 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range 1,801 KRW – 6,600 KRW · fair‑value band 5,850 KRW – 9,750 KRW · the 3,900 KRW price screens below the 7,800 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow Hanwha Life in your weekly email
Every Wednesday you see whether Hanwha Life is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Hanwha Life Insurance Co., Ltd. provides insurance products to individual and corporate customers in South Korea and internationally.
Show moreShow less
The company offers health, retirement, investment, group, accident, pension, and savings insurance products; retirement pension plans; consulting services; asset management products; and undertakes related reinsurance contracts.
It provides its products through financial planner, group financial planner, general agency, and bancassurance, as well as through online. Hanwha Life Insurance Co., Ltd. was formerly known as Korea Life Insurance Co., Ltd. and changed its name to Hanwha Life Insurance Co., Ltd. in October 2012.
The company was incorporated in 1946 and is headquartered in Seoul, South Korea.
Stock analysis
Hanwha Life (088350) currently trades at 3,900 KRW, while our model-based Fair Value estimate is 7,800 KRW, implying the stock looks roughly 50% undervalued today.
Show more
Valuation
Bull case: the Economic Profit group reads highest at a median of 14,629 KRW per share, and 3 of the 6 models we run sit above the 3,900 KRW price.
Bear case: the Dividend Discount group reads lowest at 2,287 KRW, and 3 of the 6 models stay below the price. Data coverage for this calculation is high.
Scenario range: 5,850 KRW (bear) to 9,750 KRW (bull), the price of 3,900 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 47/100 (below-average quality), in the Financial Services sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Hanwha Life reported revenue of 16.7T KRW in FY2024 versus 20.1T KRW in FY2020, a compound −4.6%/yr. Reported net income was 737B KRW in FY2024, compounding +33.1%/yr from FY2020. FY2020 was a trough year, so the rate overstates the trend.
Key figures
Market cap 2.9T KRW (≈ $2.1B) Mid · P/E ratio 3.0 · P/S ratio 0.09 · EPS (TTM) 1,310 KRW · Dividend yield 4.6% · Net margin 3.5% · Return on equity 7.9% · Return on assets (EBIT) 0.8% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 39 out of 100 (low confidence).
What moves the price
The share trades about 41% below its 52-week high and 33% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −38% fair-value upside, at 100%, 088350 screens cheaper than that median.
Fair Value models
Bear5,850 KRWFair Value 7,800 KRWBull9,750 KRW
Price 3,900 KRW · Upside +100.0%
Capped: our models arrive at a very high value here. We deliberately show a more cautious Fair Value.
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2024 figures (about 12 months old). Earnings retained since then (1,310 KRW per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.38/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−3.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−7.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.5%
Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.8%
’13
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
≈ +30.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year≈ +25.7%
Dividend (yield on the price)4.6%
⚠ Revenue per share shrinking 3.4%/yr over ~6Y (margin trend unclear) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
⚠ Base effect: the rate starts in the earnings trough around 2019 (starting value 313 per share, median 919 in 2016 to 2017). It measures the recovery from the trough, not lasting growth.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Insurance - Life · 77 stocks
Beats the industry median on 8/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score47 · Bottom 25%
Fair Value upside+100.0% · Top 25%
Profitability
Return on equity (12 months)7.9% · Bottom 25%
Return on assets0.4% · Bottom 25%
Net margin (12 months)3.5% · Bottom 25%
Operating margin (12 months)13.7% · Below median
Growth and dividend
Revenue growth (quarter YoY)57.2% · Top 25%
Dividend yield (12 months)4.6% · Above median
Balance sheet
Debt / equity0.48× · Above median
Valuation Multiplesvs Insurance - Life median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Hanwha Life Fair Value". https://www.fairvalue-calculator.com/stock/088350
Frequently asked questions
Is Hanwha Life (088350) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of 7,800 KRW versus a price of 3,900 KRW, about +100% upside (undervalued).
What is the fair value of 088350?
Our model-based fair value for Hanwha Life is 7,800 KRW (as of Nov 8, 2026), built from audited fundamentals. The current price: 3,900 KRW.
What is the quality score of 088350?
Hanwha Life has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Hanwha Life (088350)?
Our model-based price target is the fair value of 7,800 KRW (as of Nov 8, 2026) from 6 valuation models. Cautious scenario 5,850 KRW, optimistic scenario 9,750 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Hanwha Life stock forecast for 2026?
Our models put fair value at 7,800 KRW, about +100% upside versus a price of 3,900 KRW (undervalued). Cautious scenario 5,850 KRW, optimistic scenario 9,750 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Hanwha Life (088350)?
Hanwha Life reported trailing-twelve-month revenue of about 33.2T KRW (latest available figure, as of Nov 8, 2026).
Does Hanwha Life pay a dividend?
Hanwha Life currently shows a dividend yield of 4.62% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of Hanwha Life (088350)?
Hanwha Life has a dividend yield of 4.6%.
What is the intrinsic value of Hanwha Life (088350)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Hanwha Life it is 7,800 KRW per share (as of Nov 8, 2026), against a price of 3,900 KRW. It is the blended result of 6 valuation models in 4 families (Dividend Discount, Multiples, Asset-Based, Economic Profit).
Is Hanwha Life stock overvalued or undervalued in 2026?
As of Nov 8, 2026, 088350 trades below its calculated fair value: price 3,900 KRW, fair value 7,800 KRW, a gap of about +100% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 088350?
No. The price is what the market pays today (3,900 KRW); the fair value is what the company's own numbers justify (7,800 KRW). For Hanwha Life the two are 3,900 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Hanwha Life worth?
The market values Hanwha Life at about 2.9T KRW (market capitalisation, as of Nov 8, 2026). Per share that is 3,900 KRW; our models calculate a fair value of 7,800 KRW per share.
What do the bullish and bearish scenarios say about 088350?
Our models span a range for Hanwha Life: cautious scenario 5,850 KRW, base 7,800 KRW, optimistic 9,750 KRW per share (as of Nov 8, 2026, price 3,900 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 088350?
Hanwha Life trades at a price-to-earnings ratio of 3.0 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 7,800 KRW is built from several models across several years. Median P/E at fiscal year-end, 9 fiscal years (2016 to 2024), reported earnings: 6.2. Other multiples: P/B 0.2, P/S 0.1, EV/EBITDA 2.0.
How solid is the balance sheet of Hanwha Life (088350)?
Balance-sheet figures for Hanwha Life (as of Nov 8, 2026): return on equity 7.9%, debt of 0.48 per unit of equity. They feed the Quality Score of 47/100, which measures business quality independently of the share price.
How far is 088350 from its 52-week high?
Hanwha Life trades at 3,900 KRW, about 41% below its 52-week high of 6,600 KRW and 33% above the low of 2,940 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 7,800 KRW is for.
Which stocks are comparable to Hanwha Life?
From the same area (Financial Services) we also value Ping An Insurance (Group) Company, China Life Insurance Company, AIA Group, Manulife Financial Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Hanwha Life stock attractive at the current price?
The data as of Nov 8, 2026: price 3,900 KRW, calculated fair value 7,800 KRW (+100%), Quality Score 47/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 088350 calculated?
We run Hanwha Life through 6 models from 4 families: Dividend Discount, Multiples, Asset-Based, Economic Profit. Every model gets the same audited fundamentals; the fair value of 7,800 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Hanwha Life currently trades 50% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Hanwha Life (088350)?
The closing price on Nov 6, 2026 was 3,900 KRW. Our model-based fair value is 7,800 KRW, about +100% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Hanwha Life right now?
The large discount to fair value meets weak quality (47/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (5,850 KRW). The market is more pessimistic than our downside scenario. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Key figures of Hanwha Life
How large is the market capitalisation of Hanwha Life (088350)?
The market capitalisation of Hanwha Life is 2.9T KRW (≈ $2.1B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Hanwha Life (088350)?
The price-to-sales ratio of Hanwha Life is 0.09 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Hanwha Life (088350)?
Earnings per share at Hanwha Life are 1,310 KRW (price ÷ EPS = P/E 3.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Hanwha Life (088350)?
The dividend yield of Hanwha Life is 4.6% (payout 13.8%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Hanwha Life (088350)?
The net margin of Hanwha Life is 3.5% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Hanwha Life (088350)?
The return on equity (ROE) of Hanwha Life is 7.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Hanwha Life (088350)?
On an EBIT basis the return on assets of Hanwha Life is 0.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Hanwha Life (088350)?
The operating margin of Hanwha Life is 13.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Hanwha Life (088350)?
Revenue at Hanwha Life is growing +57.2% versus a year earlier (3y avg −7.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Hanwha Life (088350)?
Earnings per share at Hanwha Life are growing +240% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Hanwha Life (088350) generate?
The free cash flow of Hanwha Life is 5.1T KRW (fiscal year 2024). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Hanwha Life (088350) carry?
The net debt of Hanwha Life is 5.7T KRW (fiscal year 2025, ≈ 1.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Hanwha Life in the live analysis
One click puts Hanwha Life on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 8, 2026